Acute Mesenteric Ischemia: Diagnosis and Management

Clinical Guideline · Gastroenterology · Vascular Emergency

Acute Mesenteric Ischemia: Diagnosis and Management

Time-critical recognition of pain out of proportion to exam — CT angiography pathway, distinguishing embolic, thrombotic, NOMI, and venous etiologies, and surgical/endovascular revascularization.

📅 Updated May 2026👤 gomdori, MD⏱ 15 min read📋 WSES + ESVS aligned
Time-Critical Emergency
Acute mesenteric ischemia (AMI) is a vascular emergency with mortality of 50-80% when diagnosis is delayed beyond 12-24 hours. The cardinal feature — severe abdominal pain out of proportion to physical examination findings — must trigger immediate CT angiography (CTA) of the abdomen and pelvis with arterial and portal venous phases. Four etiologies must be distinguished: (1) SMA embolism (40-50%, typically cardioembolic from AF or recent MI), (2) SMA thrombosis (20-35%, atherosclerotic, often with chronic abdominal angina), (3) non-occlusive mesenteric ischemia (NOMI) (5-15%, low-flow state in critically ill, dialysis, vasopressor patients), and (4) mesenteric venous thrombosis (MVT) (5-15%, hypercoagulable, portal hypertension). Lactate and D-dimer have low sensitivity early; do not exclude AMI based on normal labs. Treatment is time-dependent: bowel necrosis develops within 6-12 hours of complete occlusion. Open surgical embolectomy with bowel inspection and resection of necrotic segments remains the historical standard, but endovascular thrombectomy/aspiration with stenting is increasingly first-line in stable patients without peritonitis. Anticoagulation, broad-spectrum antibiotics, fluid resuscitation, and second-look laparotomy at 24-48 hours are routine adjuncts. Survival has improved with structured AMI care pathways and multidisciplinary teams.
50-80%
Mortality (untreated/delayed)
6-12 h
Window before transmural infarct
CTA
First-line imaging (90-100% sens)
SMA emb
Most common etiology (40-50%)

Etiology & Pathophysiology

The mesenteric circulation comprises three main arteries: celiac trunk (foregut), superior mesenteric artery (SMA, midgut — duodenum to mid-transverse colon), and inferior mesenteric artery (IMA, hindgut — distal transverse colon to upper rectum). The SMA is the most clinically relevant in AMI due to the watershed nature of midgut perfusion and the SMA’s anatomical predisposition to embolic occlusion. Rich collateralization (pancreaticoduodenal arcade between celiac and SMA, marginal artery of Drummond and arc of Riolan between SMA and IMA) protects against gradual occlusion but cannot compensate for sudden embolic events.

Four Etiologic Categories

EtiologyFrequencyTypical patientPathophysiology
SMA embolism40-50%Atrial fibrillation, recent MI with mural thrombus, valvular disease, endocarditisThromboembolus lodges 3-10 cm distal to SMA origin (just past first branches); jejunum spared, distal small bowel + right colon ischemic
SMA thrombosis20-35%Atherosclerotic with chronic mesenteric angina, weight loss, food fear; smokers, peripheral vascular diseaseAcute thrombosis of pre-existing stenotic plaque at SMA origin; entire midgut + right colon ischemic
Non-occlusive mesenteric ischemia (NOMI)5-15%Critically ill, vasopressors, dialysis, post-cardiac surgery, septic shock, severe heart failureSplanchnic vasoconstriction from low cardiac output, shock, vasopressors; patchy ischemia, often mucosal
Mesenteric venous thrombosis (MVT)5-15%Hypercoagulable state (factor V Leiden, JAK2), portal hypertension, malignancy, intra-abdominal infection, OCP useThrombosis of SMV → bowel wall edema, hemorrhagic infarction; more indolent presentation (days to weeks)

Risk Factors and Triggers

  • Cardiac: Atrial fibrillation (especially if subtherapeutic anticoagulation), recent MI, dilated cardiomyopathy, infective endocarditis, mechanical valves, intracardiac thrombus
  • Atherosclerotic: Multivessel CAD, peripheral vascular disease, prior CVA, smoking, chronic mesenteric angina (postprandial pain, food fear, weight loss)
  • Hypercoagulable: Inherited thrombophilias (factor V Leiden, prothrombin G20210A, antithrombin III/protein C/S deficiency, JAK2 V617F), antiphospholipid syndrome, malignancy (especially myeloproliferative), pregnancy, OCP, recent surgery
  • Low-flow states (NOMI): Cardiogenic shock, septic shock, severe dehydration, dialysis, vasopressor use (especially norepinephrine, vasopressin), cardiopulmonary bypass
  • Mechanical: SMA dissection (rare; spontaneous or traumatic), median arcuate ligament syndrome (rare cause of celiac compression)

Clinical Presentation & Workup

Classic Triad and Presenting Features

The classic triad of acute mesenteric ischemia is (1) severe abdominal pain out of proportion to physical exam findings, (2) gut emptying (vomiting and/or diarrhea), and (3) cardiovascular risk factor for embolism or thrombosis. Pain is typically sudden onset (embolic), severe, periumbilical or diffuse, and unresponsive to opioids. Early in the course (the “ischemic phase,” first 6-12 hours), the abdomen is benign — soft, minimally tender, no peritoneal signs. As bowel infarction develops (the “infarction phase,” 12-48 hours), abdominal distension, peritonitis, hematochezia (gross blood per rectum), and septic shock emerge. By the time peritonitis develops, mortality exceeds 80%.

PhaseTimeFindings
Ischemic (early)0-6 hrSevere pain out of proportion to exam, vomiting, diarrhea, urgency; soft abdomen, no peritoneal signs
Necrotic (mid)6-12 hrProgressive distension, decreased bowel sounds, increasing tenderness, lactic acidosis; gross blood per rectum (50%)
Perforation (late)>12-24 hrPeritonitis, septic shock, multiorgan failure; mortality >80% even with surgery

Laboratory Findings (Insensitive but Suggestive)

TestFindingSensitivity / Specificity
WBCLeukocytosis >15,000 (often left shift)~75% / low
LactateElevated, often >2-4 mmol/L (late marker)~80% (late) / 60%
D-dimerElevated96% / 40% — useful negative predictive value
Anion gap metabolic acidosisLate findingLate marker — too late if abnormal at presentation
Amylase, AST, LDH, CKOften elevated (nonspecific)Variable — may suggest tissue infarction
I-FABP (intestinal fatty acid binding protein)Elevated within hours of mucosal injury~80% / 90% — promising biomarker, not widely available
Coagulation panelDIC may develop lateLate marker

🚨 Pitfall: “Normal Labs Don’t Rule Out AMI”

Normal lactate, D-dimer, and WBC do not exclude AMI in the early reversible phase. Lactate is often normal until transmural necrosis develops (6-12 hours after occlusion). The decision to perform CT angiography should be based on clinical suspicion and risk factors, not lab values. In any patient with severe abdominal pain out of proportion to exam, especially with AF, recent MI, hypercoagulable state, or critical illness, obtain CTA immediately.

ECG and Cardiac Workup

ECG is essential to identify atrial fibrillation (most common embolic source), recent MI, or rate-controlled AF in patients on subtherapeutic anticoagulation. Echocardiography (transthoracic or transesophageal) identifies intracardiac thrombus, valvular vegetations, and mural thrombus. These are part of the workup but should not delay imaging or revascularization.

Acute Mesenteric Ischemia — Comparison Comparison table: Acute Mesenteric Ischemia — Comparison SMA Embolus (40%) SMA Thrombosis (25%) MVT (15%) NOMI (20%) Description AF, recent MI, embolic events; sudden onset Atherosclerosis, postprandial pain history Hypercoagulable, portal HTN, IBD Low-flow state: cardiogenic shock, vasopressor-dependent
Acute Mesenteric Ischemia — Comparison

CT Angiography & Differential

Pancreas-Protocol or Mesenteric CTA Protocol

Multiphasic CT with arterial (25-30 sec) and portal venous (60-70 sec) phases is the diagnostic test of choice — sensitivity 90-100%, specificity 95-100%. Unenhanced phase identifies bowel wall hyperdensity (intramural hemorrhage) and pneumatosis intestinalis. Arterial phase identifies SMA filling defects, occlusions, and stenoses. Portal venous phase identifies SMV/PV thrombosis and bowel wall edema. Multiplanar reconstructions (axial, coronal, curved planar) are essential to evaluate the SMA along its course.

CTA findingEtiology suggested
Filling defect 3-10 cm distal to SMA origin, sparing first branchesSMA embolism
Calcified plaque + occlusion at SMA origin, with collateralsSMA thrombosis (acute on chronic)
Patent SMA, splanchnic vasoconstriction, “string of beads” appearanceNOMI
SMV/PV filling defect, bowel wall edema, mesenteric stranding, ascitesMesenteric venous thrombosis
Pneumatosis intestinalisTransmural infarction (any etiology) — indication for emergent laparotomy
Portal venous gasAdvanced bowel necrosis with bacterial translocation — very high mortality
Bowel wall thickening >3 mm, decreased enhancementIschemic bowel
Free intraperitoneal air, peritoneal strandingPerforation — emergent laparotomy

📌 Imaging Pitfalls and Tips

Renal insufficiency is not an absolute contraindication when AMI is clinically suspected — risk of contrast nephropathy is far outweighed by mortality of missed diagnosis. Use minimum effective contrast volume, IV hydration, and consider holding metformin. Plain abdominal radiograph is non-diagnostic but may show “thumbprinting” (bowel wall edema) or pneumatosis. Catheter angiography is rarely needed for diagnosis but offers therapeutic option (intra-arterial thrombolysis, papaverine for NOMI).
AMI Algorithm From clinical suspicion through CT angiography to etiology-specific revascularization Suspect AMI: pain out of proportion + AF/MI/CHF/dialysis/hypercoag CT Angiography (arterial + PV) DO NOT delay for normal labs SMA Embolism Open embolectomy or endovascular aspiration SMA Thrombosis Endovascular stent or surgical bypass (aorto-mesenteric) NOMI Restore perfusion Catheter papaverine stop pressors if able MVT Anticoagulation + supportive care surgery if necrosis Bowel inspection — resect necrotic segments Second-look laparotomy in 24-48 hours
Figure 1. Acute mesenteric ischemia: from clinical suspicion through etiology-directed revascularization and second-look laparotomy.
Acute Mesenteric Ischemia — Procedure Steps Surgical stepper: Acute Mesenteric Ischemia — Procedure Steps Acute Mesenteric Ischemia — Procedure Steps 1 Resuscitate Crystalloid 30 mL/kg; pRBC if Hgb <7; broad-spectrum antibiotic; correct electrolytes 2 CTA mesenteric Triphasic CTA — gold standard 95-100% sensitivity; identifies subtype 3 Heparinize (arterial AMI) Heparin 80 units/kg IV → 18 units/kg/h; immediately on diagnosis 4 SMA Embolus Endovascular thrombectomy + tPA OR open SMA embolectomy + Fogarty 5 SMA Thrombosis Open bypass (saphenous to SMA) OR retrograde stent; need patent inflow 6 MVT / NOMI MVT: anticoagulate alone; NOMI: treat shock + intra-arterial papaverine
Acute Mesenteric Ischemia — Procedure Steps

Treatment Algorithm

Initial Resuscitation (Concurrent with Imaging)

  • Two large-bore IVs; type and crossmatch; ICU consultation
  • IV fluid resuscitation — balanced crystalloid (lactated Ringer’s, Plasma-Lyte) 30 mL/kg bolus, then maintenance; avoid normal saline (may worsen acidosis)
  • Broad-spectrum IV antibiotics — piperacillin-tazobactam 4.5 g IV q8h or meropenem 1 g IV q8h; bowel translocation occurs early
  • Anticoagulation — IV unfractionated heparin 80 units/kg bolus → 18 units/kg/hr (target aPTT 1.5-2.5x baseline) — start as soon as diagnosis suspected unless active bleeding
  • NPO, NG tube decompression if distended
  • Foley catheter for urine output monitoring
  • Avoid vasopressors if possible — exacerbate splanchnic vasoconstriction; if necessary for shock, prefer norepinephrine over vasopressin or phenylephrine
  • Surgical and interventional radiology consultation immediately

Etiology-Specific Treatment

SMA Embolism

ApproachIndicationProcedure
Open surgical embolectomyPeritonitis, suspected bowel necrosis, hemodynamic instabilityMidline laparotomy → SMA exposure at root of mesentery → transverse arteriotomy → Fogarty catheter embolectomy → bowel inspection → resection of non-viable segments → consider second-look
Endovascular aspiration thrombectomyStable patient, no peritonitis, viable bowel suspectedFemoral or brachial access → SMA cannulation → mechanical aspiration thrombectomy → ± intra-arterial thrombolysis (alteplase 0.5-1 mg/hr × 24 hr)
Hybrid approachStable patient with viable bowel; multidisciplinary expertiseEndovascular revascularization + diagnostic laparoscopy or open inspection

SMA Thrombosis (Acute on Chronic)

  • Endovascular stenting — first-line in stable patients; balloon angioplasty + bare-metal or covered stent across the stenotic lesion
  • Surgical bypass — antegrade aortomesenteric bypass (preferred) or retrograde iliomesenteric bypass; reserved for failed endovascular or peritonitis
  • Mesenteric endarterectomy — historical; rarely performed

NOMI

  • Restore systemic perfusion — optimize cardiac output, correct hypovolemia, treat underlying cause (sepsis, cardiogenic shock)
  • Discontinue or minimize vasopressors if hemodynamically tolerable; norepinephrine preferred over vasopressin
  • Intra-arterial papaverine via SMA catheter 30-60 mg/hr × 24-48 hr — selective splanchnic vasodilator
  • Surgery reserved for necrosis or perforation; avoid if possible (high mortality)

Mesenteric Venous Thrombosis

  • Anticoagulation alone in stable patients without peritonitis — IV heparin → bridge to warfarin (INR 2-3) or DOAC
  • Duration: minimum 6 months; lifelong if hypercoagulable disorder identified or recurrent VTE
  • Catheter-directed thrombolysis via transjugular intrahepatic portosystemic shunt (TIPS) for extensive thrombosis or worsening despite anticoagulation
  • Surgery for bowel necrosis or perforation only; preserve maximum bowel length
  • Hypercoagulability workup: protein C/S, antithrombin III, factor V Leiden, prothrombin G20210A, JAK2 V617F, antiphospholipid antibodies, malignancy screening

Bowel Resection Principles

ApproachIndication
Preserve maximum bowel lengthAlways — short bowel syndrome (<200 cm) leads to lifelong TPN dependence
Damage control: resect frankly necrotic onlyHemodynamic instability, ambiguous viability — defer anastomosis to second look
Stapled resection without anastomosis (open ends)Damage control approach — closure at second look once viability clear
Second-look laparotomy in 24-48 hrIndicated after damage control or if viability ambiguous; reassess marginal segments
Indocyanine green (ICG) fluorescenceAdjunct for assessing perfusion and viability intraoperatively

🟢 Refer to Tertiary Vascular/HPB Center

Acute mesenteric ischemia outcomes are best at high-volume centers with combined vascular surgery, interventional radiology, hepatobiliary surgery, intensive care, and nutrition/intestinal failure expertise. If your facility lacks endovascular capability or hybrid OR, consider transfer after initial resuscitation and antibiotics — but do not delay open laparotomy if peritonitis or hemodynamic instability is present. Time to revascularization is the single most modifiable predictor of survival and bowel salvage.

💎 Pearl: “Pain Out of Proportion”

A patient writhing in agony with a soft, non-tender abdomen and AF or recent MI is acute mesenteric ischemia until proven otherwise. Do not wait for lactic acidosis or peritonitis — by then, transmural infarction has occurred and mortality exceeds 80%. Order CT angiography immediately and call vascular surgery.

⚠️ Pitfall: Delayed CTA

Common errors: ordering CT abdomen without angiography (misses arterial phase); waiting for plain films, ultrasound, or labs; delaying for renal protection labs (AKI is reversible, dead bowel is not); attributing pain to opioid-seeking, gastroenteritis, or constipation in elderly with AF. Maintain a low threshold for CTA — the cost of false-positive imaging is trivial compared to missed AMI.

Postoperative Care

ICU and Postoperative Monitoring

  • Continued IV anticoagulation — heparin infusion until bridged to warfarin (INR 2-3) or DOAC; lifelong if embolic source not eliminated, hypercoagulable, or recurrent
  • Hemodynamic optimization — maintain MAP >65 mmHg; minimize vasopressors
  • Continuous lactate monitoring — rising lactate post-op suggests ongoing ischemia, anastomotic failure, or missed necrosis → re-explore
  • Antibiotics — continue for 7-14 days based on contamination, peritonitis, anastomosis
  • Nutrition — early enteral feeding within 24-48 hr if anastomosis intact and bowel function returning; otherwise TPN if >5-7 days NPO anticipated
  • Second-look laparotomy in 24-48 hr if damage control, ambiguous viability, or extensive ischemia
  • Treat underlying source — cardiology consult for AF rate/rhythm control + anticoagulation; vascular surgery for chronic mesenteric ischemia stenting; hematology for hypercoagulability workup

Long-Term Sequelae and Follow-up

SequelaManagement
Short bowel syndrome (residual <200 cm)Intestinal failure clinic; teduglutide (GLP-2 analog) for selected; long-term TPN if <100 cm
Bowel motility disordersLoperamide, octreotide for high-output; bile acid sequestrants for bile salt malabsorption
Anastomotic strictureEndoscopic dilation; surgical revision if persistent
Recurrent thromboembolismLifelong anticoagulation; treat AF or hypercoagulable state
Chronic mesenteric ischemiaAddress other mesenteric vessels; stent or bypass if symptomatic
Nutritional deficienciesVitamin B12, fat-soluble vitamins (A, D, E, K), iron, zinc, magnesium monitoring

Long-term Pattern: Short Bowel Trajectory & Vascular Surveillance

Survivors of extensive small-bowel resection enter a parallel disease — short bowel syndrome — and the postoperative service must own this transition rather than discharging it to gastroenterology blindly. Remnant bowel under 200 cm with an absent ileocecal valve predicts dependence on parenteral nutrition; teduglutide (GLP-2 analog, 0.05 mg/kg SC daily) is the agent that reliably reduces parenteral-nutrition volume in this population, but it requires intact colonic continuity and at least 6 months of postoperative stabilization before initiation. Vascular surveillance — duplex of the SMA at 3 months, 6 months, then annually for thrombotic AMI; lifelong anticoagulation for embolic AMI from AFib or hypercoagulable states; lifetime statin plus aspirin for atherosclerotic SMA stenosis — anchors recurrence prevention. Recurrent acute mesenteric ischemia within 12 months carries near-prohibitive mortality, so the threshold to re-image any survivor who presents with abdominal pain must be extraordinarily low.

Practice Insights: What Clinicians Have Learned at the Bedside

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)Pain out of proportion to a soft abdomen is the whole of early mesenteric ischemia, and clinicians who have chased it agree that AMI is the single most diagnostically punishing emergency in abdominal medicine — not because the imaging is hard, but because the window from “abdominal pain” to “irreversible necrosis” closes faster than any escalation pathway they have worked with.

What the Guideline Misses

Published algorithms anchor on a single lactate value above 2 mmol/L, but in experienced practice the trajectory matters far more than the absolute number. What clinicians track instead is the arterial pH–bicarbonate coupling: when bicarbonate is dropping faster than the anion gap explains, transmural ischemia is usually already established, and clinicians stop waiting for confirmatory lactate.

The Four Phenotypes Seasoned Clinicians See

Experienced clinicians mentally sort every suspected AMI into one of four buckets, because the tempo and revascularization strategy diverge sharply. SMA embolism (sudden onset, atrial fibrillation, pain out of proportion) is the fastest tempo and the most endovascularly tractable. SMA thrombosis (atherosclerotic, weight loss prodrome, postprandial pain history) is slower onset, more chronic-on-acute. SMV thrombosis (subacute, hypercoagulable, prokinetic to anticoagulation) is the kindest. NOMI (low-flow, post-cardiac-arrest ICU patient, vasopressor-dependent) is the fourth.

Bedside Heuristic

Pain out of proportion to examination + new atrial fibrillation off anticoagulation + silent abdomen = SMA embolism until proven otherwise, and experienced clinicians activate CT angiography before clinicians finish the history. They do not wait for serum markers, surgical consult, or a second physician’s opinion. They treat “pain out of proportion” as a vascular-emergency keyword the way the stroke team treats “facial droop.”

Second-Look Doctrine

Every patient seasoned clinicians revascularize gets a planned second-look laparotomy at 24–36 hours, regardless of how viable the bowel looked at index operation. The segment which pinked up beautifully under warm packing at hour 6 can demarcate sharply by hour 30. Skipping the second look to “spare another anesthetic” is the most expensive false economy in this disease, and experienced practitioners do not negotiate on it even when families push back.

Illustrative Scenario

A man in his late seventies with chronic atrial fibrillation, off apixaban for an elective dental extraction, presented with eight hours of central abdominal pain that he described as “constant and wrong” — the wife noted he had become inappropriately quiet, which she found more alarming than his pain. Initial lactate was 2.1 mmol/L, examination showed soft abdomen with absent bowel sounds, and the emergency team was working up pancreatitis. The treating clinicians activated CT angiography on phenotype alone before laboratory results returned; it showed proximal SMA embolus with patchy bowel-wall enhancement loss. Endovascular thrombectomy at hour 11 from symptom onset restored flow without need for laparotomy; planned second-look CTA at 24 hours confirmed full reperfusion without infarcted segments, and he was discharged on lifelong anticoagulation.

The takeaway the treating clinicians carry: in the AFib-off-anticoagulation phenotype, they now treat “constant and wrong” pain — particularly when family describes a personality change — as activation criteria, not as a soft sign to observe further.

Protocol Adjustments to the Standard Pathway

  1. Door-to-CTA under 30 minutes, override imaging queue. For suspected AMI, clinicians treat CT angiography the way a stroke team treats non-contrast head CT — it leapfrogs everything, and the imaging tech is paged directly rather than through the radiology queue.
  2. Heparin bolus 80 units/kg the moment AMI enters the differential, before CTA confirmation, unless overt GI bleeding contraindicates it. Waiting for imaging confirmation to start anticoagulation is conceptually similar to waiting for troponin before aspirin in STEMI — by the time confirmation arrives, the clot has propagated and the salvageable bowel has shrunk.
  3. Endovascular-first for SMA embolism within six hours, open laparotomy reserved for peritoneal signs or imaging-evident transmural necrosis. The 2024 vascular literature converges on aspiration thrombectomy + tPA infusion preserving substantially more bowel length than primary laparotomy-with-embolectomy in this window, even though textbooks still default to open surgery.
  4. NOMI suspicion in any ICU patient on vasopressors with rising lactate — experienced clinicians trial a papaverine infusion via mesenteric catheter and aggressive volume + pressor weaning before clinicians send them to laparotomy. NOMI is the AMI phenotype where laparotomy is most likely to be futile, and where pharmacologic mesenteric vasodilation buys real bowel.
Acute Mesenteric Ischemia — Four Phenotype Map Tempo, lactate trajectory, and revascularization preference across SMA embolism, SMA thrombosis, SMV thrombosis, and NOMI Four Phenotypes of AMI — Tempo & Revasc Map Door-to-revasc target: under 6 hours from symptom onset SMA EMBOLISM (fastest tempo) Trigger: AFib off anticoagulation Onset: sudden, pain out of proportion Lactate: rises sharply within 4–6h Choice: endovascular thrombectomy + tPA Window: under 6h from onset ★ Highest yield from rapid CTA activation SMA THROMBOSIS (chronic-on-acute) Trigger: atherosclerosis, weight loss prodrome Onset: subacute, postprandial pain history Lactate: rises 6–12h, often less dramatic Choice: endovascular stenting or bypass Window: 6–12h with collateral support ★ Easy to mis-triage as chronic pain SMV THROMBOSIS (kindest) Trigger: hypercoagulable, OCP, cirrhosis Onset: subacute days, vague pain Lactate: often normal early Choice: heparin drip, anticoagulation alone Window: days, surgery rarely needed ★ Bowel viability usually preserved NOMI (most missed) Trigger: low-flow, post-arrest, vasopressors Onset: insidious in sedated ICU patient Lactate: rising despite source control Choice: papaverine + pressor weaning Window: hours; laparotomy often futile ★ Pharmacologic rescue before surgery
Phenotype-tempo-revascularization map clinicians use at the bedside (gold accent marks the heuristic-shift points in experienced practice).

FAQ & Pearls

Frequently Asked Questions

When is endovascular treatment preferred over open surgery?
Endovascular thrombectomy/aspiration with optional stenting is preferred for hemodynamically stable patients without peritonitis, where bowel viability is suspected to be preserved. Open laparotomy with embolectomy is mandatory when peritonitis, hemodynamic instability, suspected bowel necrosis, or signs of perforation are present. A hybrid approach (endovascular revascularization combined with laparoscopic or open bowel inspection) is increasingly used at centers with multidisciplinary expertise.
Can lactate or D-dimer rule out acute mesenteric ischemia?
No. Lactate has poor sensitivity early in the disease course (often normal until transmural infarction develops 6-12 hours after occlusion). D-dimer has high negative predictive value (~95%) but lacks specificity. Neither lab should delay CT angiography in patients with appropriate clinical suspicion. The diagnostic decision is clinical — based on pain out of proportion plus risk factors — supported by CTA.
Why are atrial fibrillation patients at especially high risk?
Atrial fibrillation accounts for 30-40% of all SMA embolism cases. Stagnant blood in the left atrial appendage forms thrombi that embolize to the systemic circulation, with the SMA being particularly susceptible due to its acute angle take-off from the aorta and the high flow demand of the gut. Subtherapeutic anticoagulation, recent cardioversion, recent paroxysmal AF, or undiagnosed AF are common scenarios. Always check ECG and review anticoagulation history in any patient presenting with sudden severe abdominal pain.
How is non-occlusive mesenteric ischemia (NOMI) different?
NOMI results from splanchnic vasoconstriction in the setting of low cardiac output, shock, or vasopressor use — without primary arterial occlusion. It typically affects critically ill patients in the ICU (cardiogenic shock, septic shock, post-cardiac surgery, dialysis). CTA shows patent SMA with diffuse splanchnic vasoconstriction (“string of beads”), often patchy ischemia. Treatment focuses on restoring systemic perfusion, weaning vasopressors when possible, and selective intra-arterial papaverine 30-60 mg/hr via SMA catheter for 24-48 hours. Surgery is reserved for established necrosis.
When do I do a second-look laparotomy?
Second-look laparotomy at 24-48 hours after initial surgery is indicated for: (1) damage control approach with deferred anastomosis, (2) ambiguous bowel viability at index operation, (3) extensive ischemia where some marginal segments were preserved, (4) clinical deterioration suggesting ongoing ischemia (rising lactate, sepsis, organ failure). Indocyanine green fluorescence imaging may guide the decision. Some centers now use diagnostic laparoscopy as a less invasive “second look.”
What is the role of anticoagulation in MVT vs arterial AMI?
Mesenteric venous thrombosis: anticoagulation is the primary treatment. IV heparin → bridge to warfarin (INR 2-3) or DOAC (apixaban, rivaroxaban). Duration ≥6 months; lifelong if hypercoagulable disorder. Surgery only for necrosis or perforation. Arterial AMI: anticoagulation is adjunctive — start heparin once diagnosis suspected to prevent clot propagation, but definitive treatment requires revascularization (open embolectomy or endovascular). Long-term anticoagulation depends on etiology (lifelong for AF, mechanical valve, recurrent embolism, hypercoagulable; selective for atherosclerotic).
What is short bowel syndrome and how do I prevent it?
Short bowel syndrome occurs when residual functional small bowel is <200 cm. Patients require lifelong nutritional support — partial TPN if 100-200 cm remain, total TPN if <100 cm. Prevention strategies during AMI surgery: (1) preserve maximum viable bowel using damage control approach, (2) avoid resecting marginal segments at index operation, (3) use ICG fluorescence to assess perfusion, (4) plan second-look laparotomy to reassess. Newer therapies for established SBS include teduglutide (GLP-2 analog) which can wean some patients off TPN. Refer to intestinal failure clinic.

💎 Pearl: AF + Sudden Pain

Any patient with atrial fibrillation (especially subtherapeutic anticoagulation or new-onset) presenting with sudden severe abdominal pain should be considered to have SMA embolism until ruled out by CTA. Door-to-CTA time should be <1 hour; door-to-revascularization <6 hours dramatically improves outcomes.

⚠️ Pitfall: Misinterpretation as Gastroenteritis

Elderly patients with vomiting and diarrhea due to early AMI are frequently misdiagnosed as viral gastroenteritis, opioid-induced constipation, or non-specific abdominal pain. The key differentiator is the disproportionate severity of pain compared to physical exam findings, plus cardiovascular risk factors. Maintain low threshold for CTA in any elderly patient with acute severe abdominal pain.
G
gomdori, MD
Gastroenterologist · Evidence-based clinical reference for practicing physicians

Leave a Reply

Your email address will not be published. Required fields are marked *